New targets in inflammatory bowel disease therapy: 2021
Purpose of review
In the rapidly progressing world of inflammatory bowel disease, this review discusses and summarizes new drug targets and results from major clinical trials in order to provide an update to physicians treating patients with inflammatory bowel diseases (IBD).
Recent findings
Multiple new mechanisms in the treatment of IBD are being developed and many are showing promising results in both ulcerative colitis and Crohn's disease patients. In addition to efficacy, some of these treatments may provide safety benefits over existing therapies.
Summary
The IBD physicians’ therapeutic armamentarium is rapidly expanding and keeping abreast of these developments is required in order to provide patients with optimized individualized care.
Source: Current Opinion in Gastroenterology - Category: Gastroenterology Tags: INFLAMMATORY BOWEL DISEASE: Edited by Miguel D. Regueiro Source Type: research
More News: Clinical Trials | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Ulcerative Colitis